Effects of Vitamin D Supplementation on Antimycobacterial Immunity

Barts & The London NHS Trust

Status: Completed

Conditions: Tuberculosis

Treatments: Drug: Ergocalciferol

Study type: Interventional

Funder types: Other

Identifiers

NCT00157066

AM1

Details and patient eligibility

About

The purpose of this study is to determine how vitamin D supplementation (ergocalciferol) affects the immune response to mycobacterial infection.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult
• Tuberculosis (TB) contact or TB patient

Exclusion criteria

• Pregnancy
• Breastfeeding
• Hyperparathyroidism
• Sarcoidosis
• Renal failure
• HIV infection